BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.

Advertising powered by artificial intelligence is a core part of Chief Executive Mark Zuckerberg's vision for the company's future. BioNTech and Bristol Myers Squibb have agreed to jointly develop and ...

Tesla delivered only 721 EVs in all of France in May, according to the latest data from French car-trade association PFA.

CNBC’s Phil LeBeau joins 'Money Movers' to discuss Tesla’s May sales.

Escalating investor concern now surrounds Elon Musk's scattered focus, particularly as Tesla's sales slump, its stock ...

Tesla shares are up more than 20% this May, putting the stock on track for its strongest monthly close since the final days ...

Elon Musk is leaving Washington after a short but turbulent stint in government and getting back to his numerous businesses, ...

Tesla sales across Europe fell by almost half (49 per cent) last month compared to a year ago, to just over 7,000 vehicles, ...

Marketing Week’s weekly round-up of the technology stories that impact the marketing sector: from AI to martech, regulation ...

With Tesla’s future hanging in the balance, a heated debate is emerging over whether the electric vehicle (EV) revolution can ...

Tesla sales in the EU slumped for a fourth consecutive month as Musk’s EV maker struggled to cash in on a growing market in ...